Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gepirone in anxiety: a pilot study.

I Csanalosi, E Schweizer, W G Case

    Journal of Clinical Psychopharmacology
    |February 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Peel bond strength between 3D printing tray materials and elastomeric impression/adhesive systems: A laboratory study.

    Dental materials : official publication of the Academy of Dental Materials·2020
    Same author

    Comparative evaluation of topographical data of dental implant surfaces applying optical interferometry and scanning electron microscopy.

    Dental materials : official publication of the Academy of Dental Materials·2017
    Same author

    Coating of ß-tricalcium phosphate scaffolds-a comparison between graphene oxide and poly-lactic-co-glycolic acid.

    Biomedical materials (Bristol, England)·2015
    Same author

    The role of current literature in psychiatric residency education.

    Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
    Same author

    Cytocompatibility evaluation of different biodegradable magnesium alloys with human mesenchymal stem cells.

    Journal of materials science. Materials in medicine·2013
    Same author

    Functional differentiation and selective inactivation of multiple Saccharomyces cerevisiae genes involved in very-long-chain fatty acid synthesis.

    Molecular genetics and genomics : MGG·2003

    Gepirone, a nonbenzodiazepine anxiolytic, significantly reduced anxiety symptoms in patients with generalized anxiety disorder. This open-label trial found gepirone to be well-tolerated and promising for anxiety treatment.

    Area of Science:

    • Psychiatry
    • Pharmacology
    • Clinical Medicine

    Background:

    • Generalized anxiety disorder (GAD) is a common mental health condition characterized by excessive worry.
    • Current treatments for GAD include pharmacotherapy and psychotherapy, with ongoing research for novel agents.
    • Nonbenzodiazepine anxiolytics represent a class of compounds explored for their potential in managing anxiety disorders.

    Purpose of the Study:

    • To evaluate the efficacy and tolerability of gepirone in patients with generalized anxiety disorder.
    • To assess the anxiolytic effects of gepirone using standardized rating scales.

    Main Methods:

    • A 6-week open-label trial involving ten patients diagnosed with GAD.
    • A single-blind placebo washout period preceded the active treatment phase.

    Related Experiment Videos

  • Patients received gepirone, with dosage adjusted, and anxiety levels were measured using the Hamilton Anxiety Scale and other physician- and patient-rated scales.
  • Main Results:

    • Mean Hamilton Anxiety scores significantly decreased from 24.8 to 7.1 (p < 0.01).
    • Comparable improvements were observed across other anxiety assessment scales.
    • The mean maximal dose of gepirone used was 41 mg.
    • Gepirone was found to be nonsedating and well-tolerated by the participants.

    Conclusions:

    • Gepirone demonstrated significant anxiolytic effects in patients with GAD.
    • The medication was well-tolerated and showed promise as a therapeutic option for anxiety.
    • Further research into gepirone for anxiety disorders is warranted.